Page 86 - HA Convention 2015

Masterclasses

MC6.3 Advances in Glaucoma Management 16:15 Convention Hall C

Monday, 18 May Management of Paediatric Glaucoma
Baig N
Department of Ophthalmology, Hong Kong Eye Hospital, Hong Kong

Paediatric glaucoma consists of a group of diseases that damage the optic nerve in paediatric patients. It is not a common
condition but it causes irreversible blindness if the diagnosis is not made promptly and treatment is delayed. Its management
includes detailed history taking, accurate ophthalmic examination which is usually performed under anaesthesia for young
patients, medical, laser and surgical treatment as well as regular evaluation. In this presentation, we shall introduce the
symptoms and signs of paediatric glaucoma, the treatment options including goniotomy, trabeculotomy, glaucoma drainage
device implantation, trabeculectomy, and laser cyclophotocoagulation. The importance of liaison between the paediatricians,
geneticists and ophthalmologists will be emphasised.

MC6.4 Advances in Glaucoma Management 16:15 Convention Hall C

HOSPITAL AUTHORITY CONVENTION 2015 Enhancing Glaucoma Care — an Introduction to Our On-going Glaucoma Programme Initiated by Coordinating
Committee in Ophthalmology
Li FCH
Department of Ophthalmology and Visual Sciences, Alice Ho Miu Ling Nethersole Hospital, Hong Kong

Since 2014, the Coordinating Committee in Ophthalmology of the Hospital Authority (HA) has initiated a programme named
“Enhancing Glaucoma Care in Hospital Authority”, with the aim to improve the quality of glaucoma care across various
clusters of HA. In this programme, we aim to raise the standard of our glaucoma service through a phased approach. In
particular, we aim at providing regular and adequate visual field (VF) tests and ocular coherence tomography (OCT) scans
for glaucoma patients in HA. Regular VF tests and OCT scans in glaucoma patients, as recommended in international
guidelines, will enable early detection of glaucoma progression, thus allowing timely intervention to prevent further
irreversible visual loss. During phase one of the programme (2014 – 2016), we have targeted at increasing the frequency of VF
tests and OCT scans for advanced/progressive glaucoma patients from every 18 months to every year. This will be followed
by two subsequent phases of the programme (phase two and phase three) which aim at further increasing the frequencies of
performing these tests for both stable and advanced/progressive glaucoma patients.

84